Cantor Fitzgerald Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
CWP
Cantor Fitzgerald Investment Advisors's PFE Position: Q2 2026 in Review
Cantor Fitzgerald Investment Advisors increased its Pfizer (PFE) stake by 0.95% in Q2 2026, buying an estimated $122K and bringing the position to 497,083 shares worth $12M. The position accounts for 0.81% of the portfolio, ranked #48.
Cantor Fitzgerald Investment Advisors first reported a position in PFE in Q2 2021 and has held it in 15 quarters since. The position peaked at $25.3M in Q1 2022. 1,267 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Cantor Fitzgerald Investment Advisors held 497,083 shares of Pfizer worth $12M as of Q2 2026.
- Cantor Fitzgerald Investment Advisors bought 4,674 Pfizer shares in Q2 2026, an estimated $122K.
- Pfizer made up 0.81% of Cantor Fitzgerald Investment Advisors's portfolio in Q2 2026, its #48 holding.
- Cantor Fitzgerald Investment Advisors first reported a position in Pfizer in Q2 2021 and has held it in 15 quarters since.
- Cantor Fitzgerald Investment Advisors's Pfizer position peaked at $25.3M in Q1 2022.
- 1,267 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Cantor Fitzgerald Investment Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.